Sacral neuromodulation versus conservative treatment for refractory idiopathic slow-transit constipation. The randomized clinical No.2-Trial.
Heemskerk SC, Dirksen CD, van Kuijk SMJ, Benninga MA, Baeten C, Masclee AAM et al.
Ann Surg 2024; 279: 746-754.
Sacral neuromodulation improved the number of patients able to defaecate on average at least three times a week (53.5 versus 3.8 per cent in controls, P=0.003), and improved their quality of life (P<0.001), in this study that included 67 patients followed for six months.
Comment: Promising, minimally invasive treatment.
30 August 2024
Read paperAcademy
Part of the charitable activity of the Foundation, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
